R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 40,000 shares at $100.11 ($4.1M) on 2013-05-22, disclosed to the SEC on 2013-05-23.
Open-market sale of $4.1M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.11 | 11,186 | $1.1M | 27.2% |
| 2 | $102.59 | 4,610 | $473K | 11.5% |
| 3 | $104.03 | 24,204 | $2.5M | 61.3% |
| Total | $102.77 avg | 40,000 | $4.1M | 100% |
| Filing → |
| ALXN | SELL | 2012-12-12 | $2.0M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |
| ALXN | SELL | 2011-10-31 | $3.1M | — | Filing → |